CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $15,000 | -60.5% | 28,240 | -8.3% | 0.00% | – |
| Q4 2015 | $38,000 | +65.2% | 30,791 | +96.3% | 0.00% | – |
| Q3 2015 | $23,000 | -42.5% | 15,683 | -24.5% | 0.00% | -100.0% |
| Q2 2015 | $40,000 | -23.1% | 20,764 | -28.3% | 0.00% | 0.0% |
| Q1 2015 | $52,000 | -31.6% | 28,974 | -10.0% | 0.00% | 0.0% |
| Q4 2014 | $76,000 | -41.1% | 32,204 | -39.6% | 0.00% | -50.0% |
| Q3 2014 | $129,000 | -29.9% | 53,286 | -18.5% | 0.00% | 0.0% |
| Q2 2014 | $184,000 | – | 65,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAGLE ASSET MANAGEMENT INC | 15,707,022 | $38,010,000 | 0.11% |
| First Heartland Consultants, Inc. | 74,624 | $181,000 | 0.08% |
| WASHINGTON TRUST Co | 410,616 | $994,000 | 0.07% |
| Geduld E E | 40,000 | $97,000 | 0.07% |
| FIRST NEW YORK SECURITIES LLC /NY | 30,562 | $73,960,000 | 0.05% |
| Crosspoint Capital Strategies, LLC | 25,000 | $61,000 | 0.04% |
| JANE STREET GROUP, LLC | 1,434,975 | $3,473,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 21,479 | $51,000 | 0.01% |
| TIAA CREF TRUST CO FSB/MO | 296,322 | $717,000 | 0.01% |
| Investors Capital Advisory Services | 16,950 | $41,000 | 0.01% |